<SEC-DOCUMENT>0001558370-24-002314.txt : 20240304
<SEC-HEADER>0001558370-24-002314.hdr.sgml : 20240304
<ACCEPTANCE-DATETIME>20240304073051
ACCESSION NUMBER:		0001558370-24-002314
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240304
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240304
DATE AS OF CHANGE:		20240304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HELIUS MEDICAL TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001610853
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				364787690
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38445
		FILM NUMBER:		24712855

	BUSINESS ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940
		BUSINESS PHONE:		215-944-6100

	MAIL ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC
		DATE OF NAME CHANGE:	20180517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20140613
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hsdt-20240304x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:hsdt="http://www.heliusmedical.com/20240304" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityCentralIndexKey" id="Tc_KmOWUftlpEWb84FNKCTNjw_2_1">0001610853</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:AmendmentFlag" id="Tc_BH7XaCj9XEimbnJs05ozUA_3_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityIncorporationStateCountryCode" id="Hidden_lxtlaqvOzEazLR4sOxwpww">DE</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="hsdt-20240304.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001610853</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:51.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:1pt;text-align:center;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:1pt;text-align:center;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_7eca3d99_64b5_4256_8662_01ce8b15fa6f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:16pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:16pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:DocumentType" id="Narr_Kf0YFS9HG0KZzMMUERcpvg"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_B1k-6I7JkkCSWNZnQFPlFw"><b style="font-weight:bold;">March 4, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;"><img src="hsdt-20240304x8k001.jpg" alt="Graphic" style="display:inline-block;height:51.75pt;width:111.75pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:24pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityRegistrantName" id="Narr_meW6BERXEkGEEJK_PlOgNQ"><b style="font-weight:bold;">HELIUS MEDICAL TECHNOLOGIES, INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_3f586fb6_e669_4f5e_a3b5_37b9e233c992"></a><a id="Tc_T78G4mZj1EmEOLydV5mkPQ_0_0"></a><a id="Tc_VdhZez7yfkOOc8KrhXuW1w_2_0"></a><a id="Tc_MpWdztn_hEa2PwEvxZXYYw_2_1"></a><a id="Tc_uyB3ymvV60GIrXPqIh35Nw_2_2"></a><a id="Tc_8MVBV9LpMUac5J8CqPy3Vg_4_0"></a><a id="Tc_qIXEZTltH0G4gto7p2XoZw_5_0"></a><a id="Tc_74Fm2CkOjUC4vbkfW1k5lg_5_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:5pt;margin:0pt;">-</p></div></div></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_lxtlaqvOzEazLR4sOxwpww;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Delaware</b></span></p></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityFileNumber" id="Tc_u-zKPn6SHUSAu_9rBWsxkg_1_1"><b style="font-weight:bold;">001-38445</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityTaxIdentificationNumber" id="Tc_9sl066Vyd0yZYOsLer2lTA_1_2"><b style="font-weight:bold;">36-4787690</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(State or other jurisdiction</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(Commission File Number)</b></p></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(IRS Employer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">Identification No.)</b></p></td></tr><tr><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityAddressAddressLine1" id="Narr_qdaZQetofEaFcFtPNnNp7w"><b style="font-weight:bold;">642 Newtown Yardley Road</b></ix:nonNumeric><b style="font-weight:bold;">,</b><b style="font-weight:bold;">&#160;</b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityAddressAddressLine2" id="Narr_fWfWsCS41kiPTfXAyfN0gw"><b style="font-weight:bold;">Suite 100</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityAddressCityOrTown" id="Narr_qbfMt3gkE0-SnwWpUXsORw"><b style="font-weight:bold;">Newtown</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityAddressStateOrProvince" id="Narr_u9IWz__UvEy0CIclRqhz6Q"><b style="font-weight:bold;">PA</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:4pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:EntityAddressPostalZipCode" id="Tc_Vfi8IwB1qE-zc2eM9Dodcg_4_2"><b style="font-weight:bold;">18940</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:36.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(Address of principal executive offices)</b></p></td><td style="vertical-align:bottom;width:33.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:4pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:30.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">(Zip Code)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: </b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:CityAreaCode" id="Narr_C9HjglrmlkGywZiuvS4BqA"><b style="font-weight:bold;">(215)</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:LocalPhoneNumber" id="Narr_mKAmAFogaUqzg_WmZt4TEQ"><b style="font-weight:bold;">944-6100</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 3pt 0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_d4d19b18_07cc_467f_ac84_4c78065bfb1d"></a><a id="Tc_WEng5Rl_IE-6ugkCjB2Eyw_1_1"></a><a id="Tc_HPdNFyZxNEexf6YK2NdD6Q_2_1"></a><a id="Tc_QoA9v8q3QEeoOtNDTQ6CtQ_3_1"></a><a id="Tc_GYsST7_1UEeyBmmuV1VJBA_4_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:9.09%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:90.9%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:9.09%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Tc_OzPhzBsqGk-i19Vck56J-A_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:90.9%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr><td style="vertical-align:top;width:9.09%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Tc_eJCaIX_O60OxwsunEyuTdA_2_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:90.9%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr><td style="vertical-align:top;width:9.09%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Tc_LWVnoZcY7EOyYsEkxblkng_3_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:90.9%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr><td style="vertical-align:top;width:9.09%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Tc_GgGy21PzA0qJSA57z6x2sQ_4_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:90.9%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_20ce40c8_b077_4e5f_a4dd_32c783822c74"></a><a id="Tc_jowAsxk_TUiV3OSZzX6xDQ_1_0"></a><a id="Tc_OoS8u7XJY0SCcof8mMAzFg_1_2"></a><a id="Tc_gXtbxJcfMU-uBY2oHL9F-g_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Symbol(s)</b></p></td><td style="vertical-align:bottom;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:40%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:Security12bTitle" id="Tc_6vctucyVtE2ZbAqzjI1iYQ_2_0">Class A Common Stock, $0.001 par value</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:16%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" name="dei:TradingSymbol" id="Tc_Nl41sx6SuUSPzlhNkM8KBw_2_2">HSDT</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:39.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_A4S4x_VeK0Gbt3gHVth0iw_2_4">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 3pt 0pt;">Emerging growth company&#160;<ix:nonNumeric contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_AQ7UYTNweE6h627Mc9hzSg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;border-bottom:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;border-bottom:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_4daeef3b_f76b_48a4_91b3_3384083e506b"></a><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:58.25pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Item 8.01</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;">Other Events</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">On March 4, 2024, Helius Medical Technologies, Inc. (the &#8220;Company&#8221;) issued a press release announcing that the Centers for Medicare &amp; Medicaid Services (CMS) has assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes to the PoNS controller and PoNS mouthpiece, effective April 1, 2024.  In addition, the Company plans to provide CMS additional information to support reimbursement economics ahead of the public meetings expected early this summer and believes there is a reasonable expectation that CMS will then determine a reimbursement amount for each of the PoNS controller and mouthpiece to be effective October 1, 2024.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">A press release issued by the Company on March 4, 2024 regarding the assignment of these HCPCS codes is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Cautionary Disclaimer Statement </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;"> </i><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Certain statements in this Current Report on Form 8-K are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements are often identified by terms such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;continue,&#8221; &#8220;will,&#8221; &#8220;goal,&#8221; &#8220;aim&#8221; and similar expressions. Such forward-looking statements include, among others, the Company&#8217;s plans to provide CMS additional information to support reimbursement economics ahead of the public meetings expected early this summer and the expectation that CMS will then determine a reimbursement amount for each of the PoNS controller and mouthpiece to be effective October 1, 2024.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;"> </i><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those expressed or implied by such statements. Important factors that could cause actual results to differ materially from the Company&#8217;s expectations include uncertainties associated with the Company&#8217;s capital requirements to achieve its business objectives, disruptions in the banking system and financial markets, the effect of macroeconomic conditions and the Company&#8217;s ability to access capital markets, the Company&#8217;s ability to continue to train physical therapists in the supervision of the use of the PoNS Treatment, the Company&#8217;s ability to secure additional contracts with rehabilitation clinics, the Company&#8217;s ability to obtain national Medicare coverage and to obtain a reimbursement code so that the PoNS device is covered by Medicare and Medicaid, the Company&#8217;s ability to build internal commercial infrastructure, secure state distribution licenses, build a commercial team and build relationships with Key Opinion Leaders, neurology experts and neurorehabilitation centers, market awareness of the PoNS device, availability of funds, manufacturing, labor shortage and supply chain risks, our ability to maintain and enforce our intellectual property rights, clinical trials and the clinical development process, the product development process, the regulatory submission review and approval process, our operating costs and use of cash, and our ability to achieve significant revenues, ongoing government regulation, and other risks detailed from time to time in the &#8220;Risk Factors&#8221; section of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, and its other filings with the United States Securities and Exchange Commission and the Canadian securities regulators, which can be obtained from either at www.sec.gov or www.sedar.com.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;"> </i><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">The reader is cautioned not to place undue reliance on any forward-looking statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law</i>.</p><a id="_1bf2e485_3365_4c7e_82a1_b76279a018c3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 9.01 </b></span><b style="font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:2.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:96.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(d)</p></td><td style="vertical-align:top;width:0.95%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:96.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Exhibits:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:5.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:0.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:93.87%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.56%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">No.</b></p></td><td style="vertical-align:bottom;width:0.56%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:93.87%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:0.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:93.87%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:0.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:93.87%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="hsdt-20240304xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release, dated March 4, 2024</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.56%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:0.56%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:93.87%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:58.3pt;text-indent:-58.3pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_07291066_24a9_44db_841c_cc24142bbcdd"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">SIGNATURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.13%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.09%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">HELIUS MEDICAL TECHNOLOGIES, INC.</b></p></td></tr><tr><td style="vertical-align:middle;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.13%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dated: March 4, 2024</p></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.13%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:46.96%;border-bottom:1px solid #000000;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">/s/&#160;Jeffrey S. Mathiesen</p></td></tr><tr><td style="vertical-align:bottom;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:3.13%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;border-top:1px solid #000000;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Jeffrey S. Mathiesen</p></td></tr><tr><td style="vertical-align:bottom;width:44.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.95%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.13%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0.75pt 0.75pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Chief Financial Officer, Treasurer and Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hsdt-20240304xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/4/2024 12:17:54 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:14pt;text-align:right;background:#ffffff;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:14pt;background:#ffffff;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><img src="hsdt-20240304xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:57.32pt;width:124.5pt;"></b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:14pt;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;padding-bottom:8pt;text-align:center;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS&#174;) Mouthpiece and Controller</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;background:#ffffff;margin:0pt;"><i style="font-size:11pt;font-style:italic;">-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (&#8220;MS&#8221;) --</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;padding-bottom:8pt;text-align:center;background:#ffffff;margin:0pt;"><i style="font-size:11pt;font-style:italic;">-- Proceeds from recent stock issuances through the Company&#8217;s At-The-Market (&#8220;ATM&#8221;) program extends cash runway into the third quarter 2024 &#8211;</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;background:#ffffff;margin:0pt;"><font style="font-size:11pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;padding-bottom:8pt;background:#ffffff;margin:0pt;"><font style="font-size:11pt;">NEWTOWN, Pa., March 4, 2024 (GLOBE NEWSWIRE) &#8211; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (&#8220;Helius&#8221; or the &#8220;Company&#8221;), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) has assigned Healthcare Common Procedure Coding System (&#8220;HCPCS&#8221;) Level II codes A4593, &#8220;Neuromodulation stimulator system, adjunct to rehabilitation therapy regime&#8221; to describe the PoNS controller and A4594, &#8220;Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each&#8221; to describe the PoNS mouthpiece. The new HCPCS codes will be effective April 1, 2024.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;padding-bottom:8pt;background:#ffffff;margin:0pt;"><font style="font-size:11pt;">&#8220;PoNS Therapy&#174; is life-changing for people who suffer gait impairment due to MS and we&#8217;re pleased that CMS understood the benefits of this innovative treatment by establishing HCPCS codes for both the PoNS mouthpiece and controller. This marks a critical reimbursement and access milestone and provides Helius the ability to begin negotiating reimbursement with third-party payers using these unique HCPCS codes. We believe there is a reasonable likelihood that at the public meetings this summer CMS will determine a reimbursement amount for each of the PoNS controller and mouthpiece to take effect on October 1, 2024,&#8221; stated Helius&#8217; President and Chief Executive Officer, Dane Andreeff.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;padding-bottom:8pt;background:#ffffff;margin:0pt;"><font style="font-size:11pt;">&#8220;As we pursue widespread reimbursement for PoNS Therapy, we have continued to manage our cash burn. With the recently announced $1.5 million of net proceeds from the sale of shares of our common stock under our ATM program at an average share price of $9.17 per share, our cash runway has been extended into the third quarter of this year. Once we establish reimbursement for PoNS, we believe we will be able to expand reimbursement across third-party payers and have a pathway to positive cash flow as we continue to pursue authorization for stroke in the U.S.,&#8221; concluded Andreeff.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;background:#ffffff;margin:0pt;"><font style="font-size:11pt;">PoNS is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from MS and is to be used as an adjunct to a supervised therapeutic exercise program. The Company is also seeking marketing authorization under PoNS&#8217;s breakthrough designation for stroke in the United States, where over five million stroke survivors are affected by walking and balance disability. In Canada, PoNS is authorized to treat balance impairment due to MS, stroke and mild-to-moderate traumatic brain injury.</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><b style="font-size:11pt;font-weight:bold;">About Helius Medical Technologies, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:14pt 0pt 8pt 0pt;"><font style="font-size:11pt;">Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain&#8217;s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company&#8217;s first commercial product is the Portable Neuromodulation Stimulator. For more information visit </font><font style="font-size:11pt;">www.heliusmedical.com</font><font style="font-size:11pt;">. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:14pt 0pt 8pt 0pt;"><b style="font-size:11pt;font-weight:bold;">About the PoNS Device and PoNS Therapy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">The Portable Neuromodulation Stimulator (PoNS) is an innovative, non-implantable, orally applied therapy that delivers neurostimulation through a mouthpiece connected to a controller and it&#8217;s used, primarily at home, with physical rehabilitation exercise, to improve balance and gait. The PoNS device, which delivers mild electrical impulses to the tongue, is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (&#8220;MS&#8221;) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">PoNS has shown effectiveness in treating gait or balance and a significant reduction in the risk of falling in stroke patients in Canada, where it received authorization for sale in three indications: (i) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke and is to be used in conjunction with physical therapy; (ii) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy. PoNS is also authorized for sale in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. For more information visit </font><font style="font-size:11pt;">www.ponstherapy.com</font><font style="font-size:11pt;">. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:14pt 0pt 8pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Cautionary Disclaimer Statement </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements are often identified by terms such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;continue,&#8221; &#8220;will,&#8221; &#8220;goal,&#8221; &#8220;aim&#8221; and similar expressions. Such forward-looking statements include, among others, statements regarding the Company&#8217;s plans to provide CMS additional information to support reimbursement economics ahead of the public meetings expected early this summer and the expectation that CMS will then determine a reimbursement amount for each of the PoNS controller and mouthpiece to be effective October 1, 2024, the success of the Company&#8217;s developmental, regulatory and commercialization efforts, the impact of HCPCS codes on the Company&#8217;s commercialization efforts, the sufficiency of the Company&#8217;s future cash position, future decisions and approvals from applicable regulatory entities in the U.S. and Canada, and the uses and effectiveness of PoNS and PoNS Therapy.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those expressed or implied by such statements. Important factors that could cause actual results to differ materially from the Company&#8217;s expectations include uncertainties </font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">associated with the Company&#8217;s capital requirements to achieve its business objectives, disruptions in the banking system and financial markets, the effect of macroeconomic conditions and the Company&#8217;s ability to access capital markets, the Company&#8217;s ability to continue to train physical therapists in the supervision of the use of the PoNS Treatment, the Company&#8217;s ability to secure additional contracts with rehabilitation clinics, the Company&#8217;s ability to obtain national Medicare coverage and to obtain a reimbursement code so that the PoNS device is covered by Medicare and Medicaid, the Company&#8217;s ability to build internal commercial infrastructure, secure state distribution licenses, build a commercial team and build relationships with Key Opinion Leaders, neurology experts and neurorehabilitation centers, market awareness of the PoNS device, availability of funds, manufacturing, labor shortage and supply chain risks, our ability to maintain and enforce our intellectual property rights, clinical trials and the clinical development process, the product development process, the regulatory submission review and approval process, our operating costs and use of cash, and our ability to achieve significant revenues, ongoing government regulation, and other risks detailed from time to time in the &#8220;Risk Factors&#8221; section of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, and its other filings with the United States Securities and Exchange Commission and the Canadian securities regulators, which can be obtained from either at www.sec.gov or www.sedar.com.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;">The reader is cautioned not to place undue reliance on any forward-looking statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Investor Relations Contact</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Lisa M. Wilson, In-Site Communications, Inc.</font><font style="font-size:11pt;"><br></font><font style="font-size:11pt;">T: 212-452-2793</font><font style="font-size:11pt;"><br></font><font style="font-size:11pt;">E:&#160;</font><font style="font-size:11pt;">lwilson@insitecony.com</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>hsdt-20240304x8k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 hsdt-20240304x8k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !H . # 2(  A$! Q$!_\0
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MRNW_ (F?/\3TH4<TJ4Z:M%*-DO\ "@HHHKZ4^5"BBB@ HHHH **** "BBB@
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M_P SE_UZQ?\ L]?GS>_\?EQ_UU?_ -"->]A/^15AO^W_ /THZ<#_ ,C?'?\
M</\ ])9#7W5_P3=_Y%[QS_U]VO\ Z ]?"M?=7_!-W_D7O'/_ %]VO_H#UZN5
M?[W'Y_D8<5_\BBK_ -N_^E(^RZ^/_P#@H7_R#/!?_7>Y_P#0%K[ KX__ ."A
M?_(,\%_]=[G_ - 6OOX[GX"]CGO^"?(SXK\7?]>4'_HPU]P8'H*^(/\ @GS_
M ,C7XN_Z\H/_ $8:^X*);BCL<S\2P/\ A7OB3C_F'S_^BS7YC_ S_DK7@O\
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M "L2,84>M>HUQU_\6/#NG^+=1\-R7,CZKI^G-JES%'$66.%2!RW3=R#MZXK
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M4,,A,C87=Y9;GK]ZM6R\81>#/'8M/AUJ^I7\FH:FQU#P3J6GR?Z/N)\R='8
,QJ3SDDJ:**+ ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>hsdt-20240304xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 hsdt-20240304xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !S /D# 2(  A$! Q$!_\0
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M (U^2/EJ_P#R/Z7_ %Z?_I1\WTAZ'Z4M(>A^E=1]4?L=\*_^28>$/^P/9_\
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MI-Q'9ZC9SW,?GPQ2H\L?7> 02.?6OMJ']O\ \*6\211>$]8CC10JHLD("@<
M#YJ^(M-BAEO;6.[=H[=I$69TY8+D!B/>ONFR_8-^'VHV4%U!K_B*2">-98V\
MZ#E6&0?]3Z&G*W4%?H9NH_M\^%M0T^YM6\*ZQMFC:,[GA(Y&.1NKXJDN -1>
M>W+1CSC)&>A7YLC\J^[?^& ? G_0=\1_]_K?_P",TH_8"\" Y_MWQ%_W^M__
M (U4II#:;.R^-UP]W^RSJL\DAEDDT6%V<G)8E%R3^-?!7P9_Y*SX2_["4/\
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*<L?^_=%%0P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hsdt-20240304.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/4/2024 12:17:58 PM-->
<!--Modified on: 3/4/2024 12:17:58 PM-->
<xsd:schema targetNamespace="http://www.heliusmedical.com/20240304" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:hsdt="http://www.heliusmedical.com/20240304" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="hsdt-20240304_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="hsdt-20240304_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hsdt-20240304_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/4/2024 12:17:58 PM-->
<!--Modified on: 3/4/2024 12:17:58 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hsdt-20240304_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/4/2024 12:17:58 PM-->
<!--Modified on: 3/4/2024 12:17:58 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="hsdt-20240304.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638451514788545253" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638451514788545253" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638451514788545253" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638451514788545253" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638451514788545253" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638451514788545253" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638451514788545253" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638451514788545253" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638451514788545253" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638451514788545253" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638451514788545253" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638451514788545253" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638451514788555291" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638451514788555291" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638451514788555291" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638451514788555291" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638451514788555291" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638451514788555291" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638451514788555291" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638451514788555291" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638451514788555291" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638451514788555291" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638451514788565263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638451514788565263" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638451514788565263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638451514788565263" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638451514788565263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638451514788565263" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140458779992384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  04,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HELIUS MEDICAL TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001610853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4787690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">642 Newtown Yardley Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newtown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">18940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">944-6100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HSDT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " #9.V18F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M -D[9%A#=O%??P0  &$1   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #9.V18GZ ;\+$"  #B#   #0
M            @ '"#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -D[9%B7
MBKL<P    !,"   +              "  9X/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( -D[9%@<.&7J/P$  #P"   /              "  8<0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " #9.V18)!Z;HJT   #X 0  &@
M        @ 'S$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " #9.V1899!YDAD!  #/ P  $P              @ '8$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   B%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hsdt-20240304x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>hsdt-20240304.xsd</File>
    <File>hsdt-20240304_lab.xml</File>
    <File>hsdt-20240304_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="hsdt-20240304x8k.htm">hsdt-20240304x8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>hsdt-20240304x8k001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hsdt-20240304x8k.htm": {
   "nsprefix": "hsdt",
   "nsuri": "http://www.heliusmedical.com/20240304",
   "dts": {
    "schema": {
     "local": [
      "hsdt-20240304.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hsdt-20240304_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hsdt-20240304_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "hsdt-20240304x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hsdt-20240304x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hsdt-20240304x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.heliusmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001558370-24-002314-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-002314-xbrl.zip
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MZM[?\VZ,_S:ZT('>P-]\_95WGCZ$8Y?:*;K_\/TQVU^[*\).Y?X?4$L#!!0
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M#.#*707IB"WY8';Q5N%R\S]02P,$%     @ V3MD6.]K!66M!   E2@  !4
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MJ!<567U<(<A3Z"IUF-[EI6JTWW<=T#D8CM2<(=&8Y0P0*'R(H)-<XH2T0,
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M<[( I>!2SW<#'1EQ)T(1YR2D,=\U-6Y]$A (S/:0]$1O--Z-SZ@@./%,1-"
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MET8U(^@Y52 7S5 +_'/0 UHV"_BC'$VV133.:^V#'9EV>^;K"G<=?T*[/5F
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M"4M?FIVNEL2X\(*:SU5((%\<%6!A8NB\OO]GC&*O<][_U.G.@0HD>9'HN0I
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M#^#/7TZ6+W,=W<65!^Y[^/S%_C?_ U!+ 0(4 Q0    ( -D[9%BWE_$7? ,
M %\,   1              "  0    !H<V1T+3(P,C0P,S T+GAS9%!+ 0(4
M Q0    ( -D[9%B,O/0-A 4  (4^   5              "  :L#  !H<V1T
M+3(P,C0P,S T7VQA8BYX;6Q02P$"% ,4    " #9.V18[VL%9:T$  "5*
M%0              @ %B"0  :'-D="TR,#(T,#,P-%]P<F4N>&UL4$L! A0#
M%     @ V3MD6+2K@>?6&P  J<$  !0              ( !0@X  &AS9'0M
M,C R-# S,#1X.&LN:'1M4$L! A0#%     @ V3MD6,,.N"=C&0  \1H  !<
M             ( !2BH  &AS9'0M,C R-# S,#1X.&LP,#$N:G!G4$L! A0#
M%     @ V3MD6 RFBH\2$0  K$   !@              ( !XD,  &AS9'0M
I,C R-# S,#1X97@Y.60Q+FAT;5!+!08     !@ & )(!   J50     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>hsdt-20240304x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hsdt-20240304.xsd" xlink:type="simple"/>
    <context id="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610853</identifier>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_KmOWUftlpEWb84FNKCTNjw_2_1">0001610853</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_BH7XaCj9XEimbnJs05ozUA_3_1">false</dei:AmendmentFlag>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Hidden_lxtlaqvOzEazLR4sOxwpww">DE</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentType
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_Kf0YFS9HG0KZzMMUERcpvg">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_B1k-6I7JkkCSWNZnQFPlFw">2024-03-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_meW6BERXEkGEEJK_PlOgNQ">HELIUS MEDICAL TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_u-zKPn6SHUSAu_9rBWsxkg_1_1">001-38445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_9sl066Vyd0yZYOsLer2lTA_1_2">36-4787690</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_qdaZQetofEaFcFtPNnNp7w">642 Newtown Yardley Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_fWfWsCS41kiPTfXAyfN0gw">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_qbfMt3gkE0-SnwWpUXsORw">Newtown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_u9IWz__UvEy0CIclRqhz6Q">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_Vfi8IwB1qE-zc2eM9Dodcg_4_2">18940</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_C9HjglrmlkGywZiuvS4BqA">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_mKAmAFogaUqzg_WmZt4TEQ">944-6100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_OzPhzBsqGk-i19Vck56J-A_1_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_eJCaIX_O60OxwsunEyuTdA_2_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_LWVnoZcY7EOyYsEkxblkng_3_0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_GgGy21PzA0qJSA57z6x2sQ_4_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_6vctucyVtE2ZbAqzjI1iYQ_2_0">Class A Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_Nl41sx6SuUSPzlhNkM8KBw_2_2">HSDT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Tc_A4S4x_VeK0Gbt3gHVth0iw_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_3_4_2024_To_3_4_2024_ysegKCUFu0Klq1FZpgiQwA"
      id="Narr_AQ7UYTNweE6h627Mc9hzSg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
